(Q46891654)

26 December 2017

title

Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy male subjects (English)

1 reference

26 December 2017

1 reference

1 reference

1 reference

Ping Liu

1

1 reference

26 December 2017

Grover Foster

2

1 reference

26 December 2017

Robert R LaBadie

3

1 reference

26 December 2017

Maria J Gutierrez

4

1 reference

26 December 2017

Amarnath Sharma

5

1 reference

26 December 2017

publication date

19 November 2007

1 reference

26 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

26 December 2017

volume

48

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

73-84

1 reference

26 December 2017

Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309703

Review of the safety and efficacy of voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309703

Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309703

Voriconazole potentiates warfarin‐induced prothrombin time prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309703

Effect of omeprazole on the steady‐state pharmacokinetics of voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309703

Identification of the Cytochrome P450 Enzymes Involved in theN-Oxidation of Voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309703

Pharmacokinetics of voriconazole and cytochrome P450 2C19 genetic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309703

Genetic polymorphism of cytochrome P450 2C19 in Mexican Americans: a cross-ethnic comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309703

Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309703

Induction of CYP3A4 by efavirenz in primary human hepatocytes: comparison with rifampin and phenobarbital

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309703

Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309703

Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309703

The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309703

The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309703

Enzyme induction and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309703

Clinical Implications of Enzyme Induction and Enzyme Inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007309703

21 January 2018

Identifiers

DOI

10.1177/0091270007309703

1 reference

26 December 2017

PubMed ID

18025525

1 reference

26 December 2017